Mark S. Tichenor
- Organic Chemistry top 10%
- Molecular Biology
- Pharmacology top 10%
- Toxicology top 5%
- Cancer Research
- Co-authors
- Dale L. BogerDavid B. KastrinskyInkyu HwangJohn D. TrzupekJ. M. O’ConnorThomas J. RaylKaren S. MacMillanMark Seierstad
- Topics
- Cannabis and Cannabinoid Research (4 papers)Cancer therapeutics and mechanisms (3 papers)Microbial Natural Products and Biosynthesis (2 papers)
- Partner nations
- United StatesBelgiumItaly
In The Last Decade
Mark S. Tichenor
13 papers receiving 450 citations
Peers
Comparison fields: 5 of 61
- Organic Chemistry 281
- Molecular Biology 215
- Pharmacology 122
- Toxicology 43
- Cancer Research 34
Countries citing papers authored by Mark S. Tichenor
This map shows the geographic impact of Mark S. Tichenor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark S. Tichenor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark S. Tichenor more than expected).
Fields of papers citing papers by Mark S. Tichenor
This network shows the impact of papers produced by Mark S. Tichenor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark S. Tichenor. The network helps show where Mark S. Tichenor may publish in the future.
Co-authorship network of co-authors of Mark S. Tichenor
This figure shows the co-authorship network connecting the top 25 collaborators of Mark S. Tichenor. A scholar is included among the top collaborators of Mark S. Tichenor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark S. Tichenor. Mark S. Tichenor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 7 | |
| 3 | 2 | |
| 4 | 11 | |
| 5 | 11 | |
| 6 | 47 | |
| 7 | 20 | |
| 8 | 31 | |
| 9 | 65 | |
| 10 | 31 | |
| 11 | 38 | |
| 12 | 65 | |
| 13 | 87 | |
| 14 | 40 |
About Mark S. Tichenor
Mark S. Tichenor is a scholar working on Toxicology, Pharmacology and Molecular Medicine, having authored 14 papers that have together received 455 indexed citations. Recurring topics across this work include Cannabis and Cannabinoid Research (4 papers), Cancer therapeutics and mechanisms (3 papers) and Microbial Natural Products and Biosynthesis (2 papers). The work is most often cited by research in Toxicology (43 citations), Organic Chemistry (281 citations) and Pharmacology (122 citations). Mark S. Tichenor has collaborated with scholars based in United States, Belgium and Italy. Frequent co-authors include Dale L. Boger, David B. Kastrinsky, Inkyu Hwang, John D. Trzupek, J. M. O’Connor, Thomas J. Rayl, Karen S. MacMillan, Mark Seierstad, Sandra R. Chaplan and J. Guy Breitenbucher. Their work appears in journals such as Journal of the American Chemical Society, Journal of Clinical Investigation and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.